RaysightMed
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RaysightMed - overview
Established
2017
Location
Shenzhen, Guangdong, China
Primary Industry
Medical Devices & Equipment
About
Based in Shenzhen, China abd founded in 2017. Shenzhen RaysightMed Co, Ltd. , dba RaisightMed, provides wearable devices. In May 2026, RaysightMed closed Series D funding from Jinkong Fund Management and Guangzhou Yuefu Fund Management.
The company's products and services have cover the diagnosis and treatment of cardiovascular, cerebrovascular and peripheral blood vessels, including preoperative evaluation, risk analysis, surgical planning, consumables simulation, consumables selection and effect evaluation. At present, Ruixin-FFR has covered more than 500 hospitals, with more than 50000 actual clinical application cases. The research and development employee of the company accounts for more than half of the team, the technical teams have worked in GE, Siemens, Da Vinci surgical robot and other enterprises for many years. The company generates revenue from the sales of wearable medical device for vital signs monitoring.
Current Investors
MPCi, CASH Capital, China Growth Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Medical Devices & Equipment, Medical Software, Biomaterials
Website
www.raysightmed.com
Verticals
IoT (Internet of Things)
Company Stage
Series D
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.